IJRTI
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.14

Issue per Year : 12

Volume Published : 10

Issue Published : 115

Article Submitted : 19457

Article Published : 8041

Total Authors : 21252

Total Reviewer : 769

Total Countries : 144

Indexing Partner

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: RECENT PERSPECTIVE IN MEDICATION FOR ALOPECIA ARAETA.
Authors Name: Miss. Pranali Vijay Jamdade , Dr. Ajay Shinde
Download E-Certificate: Download
Author Reg. ID:
IJRTI_189137
Published Paper Id: IJRTI2402017
Published In: Volume 9 Issue 2, February-2024
DOI:
Abstract: Alopecia areata (AA) is a common autoimmune disease that causes unexpected, recurrent patchy hair loss. Its chronic pathogenesis remains mostly unknown. The ability of hair follicles to regenerate is preserved indefinitely as the follicles are not completely damaged. A patchy AA is the most prevalent kind. The most common related diseases are autoimmune thyroiditis and atopy. Histopathology is characterized by peribulbar and intrabulbar lymphocytic inflammatory infiltrates that resemble a "swarm of bees." The main objective of treatment is to reduce the activity of the illness. The recommended medications for topical, intralesional, or systemic therapy are corticosteroids. The current AA therapies have low efficacy rates ranging from 23% to 75%. There are many therapeutic alternatives available, however, there is a high recurrence rate and certain adverse effects connected with the present treatment choices, thus the quest for novel techniques is still ongoing. In difficult situations, wigs may serve as an alternate type of camouflage.
Keywords: New Treatment, Alopecia areata, Scar-free, Hair loss; Autoimmune Diseases, Nonscarring alopecia, Camouflage.
Cite Article: "RECENT PERSPECTIVE IN MEDICATION FOR ALOPECIA ARAETA.", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.9, Issue 2, page no.91 - 102, February-2024, Available :http://www.ijrti.org/papers/IJRTI2402017.pdf
Downloads: 000205116
ISSN: 2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID: IJRTI2402017
Registration ID:189137
Published In: Volume 9 Issue 2, February-2024
DOI (Digital Object Identifier):
Page No: 91 - 102
Country: Pune, Maharashtra , India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2402017
Published Paper PDF: https://www.ijrti.org/papers/IJRTI2402017
Share Article:

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijrti.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

ISSN Details

ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED, Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI.ONE
How to Get DOI?

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Join RMS/Earn 300

IJRTI

WhatsApp
Click Here

Indexing Partner